Wellcome Manufacturing Facility for First-in-Patient Complex Medical Devices

Within five years, a new manufacturing facility will produce two types of complex medical devices for the first time in patients: a Multi-Modal Surgical Instrument and an Active Implantable Medical Device. The problem is a gap in the UK’s translation pipeline. Promising medical device prototypes developed in university labs often stall because no dedicated facility exists to manufacture them at the quality and scale needed for first-in-human trials. This facility fills that gap, turning research concepts into physical devices ready for clinical evaluation. If successful, the facility could improve quality of life for patients and carers, potentially reducing healthcare costs. It also creates a clear pathway for accelerating Wellcome- and EPSRC-funded research. Beyond individual devices, the centre will support small and medium-sized enterprises (SMEs) by providing manufacturing expertise and capacity, enabling the next step toward larger-scale production. Crucially, it will also develop innovative manufacturing processes that could produce devices currently inconceivable with existing methods—quietly strengthening the UK’s medical device infrastructure and supply chains.